| Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis A Nouri, L Tetreault, A Singh, SK Karadimas, MG Fehlings Spine 40 (12), E675-E693, 2015 | 861 | 2015 |
| Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder S Kalsi-Ryan, SK Karadimas, MG Fehlings The Neuroscientist 19 (4), 409-421, 2013 | 464 | 2013 |
| Pathophysiology and natural history of cervical spondylotic myelopathy SK Karadimas, WM Erwin, CG Ely, JR Dettori, MG Fehlings Spine 38 (22S), S21-S36, 2013 | 431 | 2013 |
| Pathobiology of cervical spondylotic myelopathy SK Karadimas, G Gatzounis, MG Fehlings European Spine Journal 24, 132-138, 2015 | 243 | 2015 |
| A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research SK Karadimas, ES Moon, WR Yu, K Satkunendrarajah, JK Kallitsis, ... Neurobiology of disease 54, 43-58, 2013 | 152 | 2013 |
| Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy SK Karadimas, AM Laliberte, L Tetreault, YS Chung, P Arnold, WD Foltz, ... Science translational medicine 7 (316), 316ra194-316ra194, 2015 | 106 | 2015 |
| Synergistic effects of self-assembling peptide and neural stem/progenitor cells to promote tissue repair and forelimb functional recovery in cervical spinal cord injury M Iwasaki, JT Wilcox, Y Nishimura, K Zweckberger, H Suzuki, J Wang, ... Biomaterials 35 (9), 2617-2629, 2014 | 102 | 2014 |
| Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy PM Vidal, SK Karadimas, A Ulndreaj, AM Laliberte, L Tetreault, S Forner, ... JCI insight 2 (11), 2017 | 80 | 2017 |
| Cervical excitatory neurons sustain breathing after spinal cord injury K Satkunendrarajah, SK Karadimas, AM Laliberte, G Montandon, ... Nature 562 (7727), 419-422, 2018 | 72 | 2018 |
| Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy ES Moon, SK Karadimas, WR Yu, JW Austin, MG Fehlings Neurobiology of disease 62, 394-406, 2014 | 72 | 2014 |
| The natural history of degenerative cervical myelopathy and the rate of hospitalization following spinal cord injury: an updated systematic review LA Tetreault, S Karadimas, JR Wilson, PM Arnold, S Kurpad, JR Dettori, ... Global Spine Journal 7 (3_suppl), 28S-34S, 2017 | 59 | 2017 |
| Sensory cortical control of movement SK Karadimas, K Satkunendrarajah, AM Laliberte, D Ringuette, ... Nature neuroscience 23 (1), 75-84, 2020 | 57 | 2020 |
| Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection K Satkunendrarajah, F Nassiri, SK Karadimas, A Lip, G Yao, MG Fehlings Experimental neurology 276, 59-71, 2016 | 57 | 2016 |
| Bilateral contusion-compression model of incomplete traumatic cervical spinal cord injury N Forgione, SK Karadimas, WD Foltz, K Satkunendrarajah, A Lip, ... Journal of neurotrauma 31 (21), 1776-1788, 2014 | 57 | 2014 |
| New experimental rabbit animal model for cervical spondylotic myelopathy G Klironomos, S Karadimas, A Mavrakis, P Mirilas, I Savvas, E Papadaki, ... Spinal Cord 49 (11), 1097-1102, 2011 | 49 | 2011 |
| Immunohistochemical profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy SK Karadimas, G Klironomos, DJ Papachristou, S Papanikolaou, ... Spine 38 (1), 4-10, 2013 | 48 | 2013 |
| Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial MG Fehlings, JR Wilson, SK Karadimas, PM Arnold, B Kopjar Spine 38 (22S), S68-S75, 2013 | 46 | 2013 |
| Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury SA Figley, Y Liu, SK Karadimas, K Satkunendrarajah, P Fettes, SK Spratt, ... PloS one 9 (5), e96137, 2014 | 39 | 2014 |
| The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy SK Karadimas, CH Gialeli, G Klironomos, GN Tzanakakis, ... Current medicinal chemistry 17 (11), 1048-1058, 2010 | 30 | 2010 |
| Mir21 modulates inflammation and sensorimotor deficits in cervical myelopathy: data from humans and animal models AM Laliberte, SK Karadimas, PM Vidal, K Satkunendrarajah, MG Fehlings Brain Communications 3 (1), fcaa234, 2021 | 28 | 2021 |
